Literature DB >> 23475155

Potassium iodide (KI) to block the thyroid from exposure to I-131: current questions and answers to be discussed.

Christoph Reiners1, Rita Schneider.   

Abstract

Thyroid cancer in children and adolescents has to be considered as the most severe health consequence of a nuclear reactor emergency with release of radioiodine into the atmosphere. High doses of potassium iodide are effective to block radioiodine thyroid uptake and to prevent development of thyroid cancer years later. However, there are controversies concerning thyroid cancer risk induced by radioiodine exposure in adults. Further, the interaction of nutritional supply of potassium iodide and radioiodine uptake as well as the interaction of radioiodine with certain drugs has not been addressed properly in existing guidelines and recommendations. How to proceed in case of repeated release of radioiodine is an open, very important question which came up again recently during the Fukushima accident. Lastly, the side effects of iodine thyroid blocking and alternatives of this procedure have not been addressed systematically up to now in guidelines and recommendations. These questions can be answered as follows: in adults, the risk to develop thyroid cancer is negligible. In countries, where nutritional iodine deficiency is still an issue, the risk to develop thyroid cancer after a nuclear reactor emergency has to be considered higher because the thyroid takes up more radioiodine as in the replete condition. Similarly, in patients suffering from thyrotoxicosis, hypothyroidism or endemic goitre not being adequately treated radioiodine uptake is higher than in healthy people. In case of repeated or continued radioiodine release, more than one dose of potassium iodide may be necessary and be taken up to 1 week. Repeated iodine thyroid blocking obviously is not harmful. Side effects of iodine thyroid blocking should not be overestimated; there is little evidence for adverse effects in adults. Newborns and babies, however, may be more sensitive to side effects. In the rare case of iodine hypersensitivity, potassium perchlorate may be applied as an alternative to iodine for thyroid blocking.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23475155     DOI: 10.1007/s00411-013-0462-0

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  21 in total

Review 1.  Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use.

Authors:  D V Becker; P Zanzonico
Journal:  Thyroid       Date:  1997-04       Impact factor: 6.568

Review 2.  Adverse effects of iodine thyroid blocking: a systematic review.

Authors:  L Spallek; L Krille; C Reiners; R Schneider; S Yamashita; H Zeeb
Journal:  Radiat Prot Dosimetry       Date:  2011-10-20       Impact factor: 0.972

Review 3.  Implications of the molecular characterization of the sodium-iodide symporter (NIS).

Authors:  C Schmutzler; J Köhrle
Journal:  Exp Clin Endocrinol Diabetes       Date:  1998       Impact factor: 2.949

4.  Protection of the infant thyroid from radioactive contamination by the administration of stable iodide. An experimental evaluation in chimpanzees.

Authors:  J L Noteboom; W A Hummel; J J Broerse; J J de Vijlder; T Vulsma; D W van Bekkum
Journal:  Radiat Res       Date:  1997-06       Impact factor: 2.841

5.  Transient hypothyroidism or persistent hyperthyrotropinemia in neonates born to mothers with excessive iodine intake.

Authors:  Soroku Nishiyama; Tomohiro Mikeda; Toshihisa Okada; Kimitoshi Nakamura; Tomio Kotani; Akira Hishinuma
Journal:  Thyroid       Date:  2004-12       Impact factor: 6.568

Review 6.  Iodine nutrition and the risk from radioactive iodine: a workshop report in the chernobyl long-term follow-up study.

Authors:  J Robbins; J T Dunn; A Bouville; V I Kravchenko; J Lubin; S Petrenko; K M Sullivan; L Vanmiddlesworth; J Wolff
Journal:  Thyroid       Date:  2001-05       Impact factor: 6.568

7.  Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism.

Authors:  F Bogazzi; L Bartalena; S Brogioni; G Scarcello; A Burelli; A Campomori; L Manetti; G Rossi; A Pinchera; E Martino
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

8.  Thyroid cancer risk after thyroid examination with 131I: a population-based cohort study in Sweden.

Authors:  Paul W Dickman; Lars-Erik Holm; Göran Lundell; John D Boice; Per Hall
Journal:  Int J Cancer       Date:  2003-09-10       Impact factor: 7.396

9.  Kinetics of [123I]iodide uptake and discharge by perchlorate in studies of inhibition of iodide binding by antithyroid drugs.

Authors:  D C McCruden; T E Hilditch; J M Connell; W D Alexander
Journal:  Acta Endocrinol (Copenh)       Date:  1985-12

10.  The impact of iodine prophylaxis on thyroid 131-iodine uptake in the region of Krakow, Poland.

Authors:  B Huszno; A Hubalewska-Hoła; A Bałdys-Waligórska; A Sowa-Staszczak; Z Szybiński
Journal:  J Endocrinol Invest       Date:  2003       Impact factor: 4.256

View more
  11 in total

1.  Caveats in the use of potassium iodide for thyroid blocking.

Authors:  Georgios Meristoudis; Ioannis Ilias
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-11       Impact factor: 10.057

2.  Effect of repetitive potassium iodide on thyroid and cardiovascular functions in elderly rats.

Authors:  Dalila Lebsir; Elsa Cantabella; David Cohen; Amandine Sache; Teni Ebrahimian; Dimitri Kereselidze; Mohamed Amine Benadjaoud; François Caire Maurisier; Pierre Guigon; Jean René Jourdain; Marc Benderitter; Philippe Lestaevel; Maâmar Souidi
Journal:  Biochem Biophys Rep       Date:  2020-09-30

3.  Repeated KI Prophylaxis in Case of Prolonged Exposure to Iodine Radioisotopes: Pharmacokinetic Studies in Adult Rats.

Authors:  Guillaume Phan; Rym Chioukh; David Suhard; Alexandre Legrand; Charlotte Moulin; Thibaud Sontag; François Rebière; Céline Bouvier-Capely; Michelle Agarande; Valérie Renaud-Salis; Jean-René Jourdain
Journal:  Pharm Res       Date:  2018-10-08       Impact factor: 4.200

4.  High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation.

Authors:  Claudia T Mendler; Lars Friedrich; Iina Laitinen; Martin Schlapschy; Markus Schwaiger; Hans-Jürgen Wester; Arne Skerra
Journal:  MAbs       Date:  2015       Impact factor: 5.857

5.  Optimal KI Prophylactic Dose Determination for Thyroid Radiation Protection After a Single Administration in Adult Rats.

Authors:  Guillaume Phan; François Rebière; David Suhard; Alexandre Legrand; Floriane Carpentier; Thibaud Sontag; Maâmar Souidi; Jean-René Jourdain; Michelle Agarande; Valérie Renaud-Salis
Journal:  Dose Response       Date:  2017-12-13       Impact factor: 2.658

6.  Iodide transport: implications for health and disease.

Authors:  Liuska Pesce; Peter Kopp
Journal:  Int J Pediatr Endocrinol       Date:  2014-05-30

Review 7.  The hypothalamic-pituitary-thyroid axis in infants and children: protection from radioiodines.

Authors:  Jeffrey Fisher; Xiaoxia Yang; Curtis Harris; Igor Koturbash; Annie Lumen
Journal:  J Thyroid Res       Date:  2014-05-25

Review 8.  Managing terrorism or accidental nuclear errors, preparing for iodine-131 emergencies: a comprehensive review.

Authors:  Eric R Braverman; Kenneth Blum; Bernard Loeffke; Robert Baker; Florian Kreuk; Samantha Peiling Yang; James R Hurley
Journal:  Int J Environ Res Public Health       Date:  2014-04-15       Impact factor: 3.390

9.  Pharmacokinetics and Scintigraphic Imaging of the Hypoxia-Imaging Agent [123I]IAZA in Healthy Adults Following Exercise-Based Cardiac Stress †.

Authors:  Daria Stypinski; Stephen A McQuarrie; Alexander J B McEwan; Leonard I Wiebe
Journal:  Pharmaceutics       Date:  2018-02-22       Impact factor: 6.321

10.  A comparison of thyroidal protection by stable iodine or perchlorate in the case of acute or prolonged radioiodine exposure.

Authors:  Stefan Eder; Cornelius Hermann; Andreas Lamkowski; Manabu Kinoshita; Tetsuo Yamamoto; Michael Abend; Nariyoshi Shinomiya; Matthias Port; Alexis Rump
Journal:  Arch Toxicol       Date:  2020-07-12       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.